HPV16 E6-induced and E6AP-dependent inhibition of the transcriptional coactivator hADA3 in human cervical carcinoma cells

Cancer Investigation

Volumn 27, Issue 3, 2009, Pages 298-306

  Hu, Ying ^a   Ye, Feng ^a   Lu, Weiguo ^a   Hong, Die ^a   Wan, Xiaoyun ^a   Xie, Xing ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Cervical carcinoma; E6; E6AP; hADA3; Human papillomavirus

Indexed keywords

HADA3 PROTEIN; PROTEIN; PROTEIN E6; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN; TADA3L PROTEIN, HUMAN; TRANSCRIPTION FACTOR; UBE3A PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN PAPILLOMAVIRUS TYPE 16; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RNA INTERFERENCE; UTERINE CERVIX CARCINOMA; DRUG ANTAGONISM; GENETICS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES; UTERINE CERVICAL NEOPLASMS;

EID: 63349111398     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802350798     Document Type: Article

References (22)

1. Zur Hausen, H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000, 92, 690-698. (Pubitemid 30365529)
2. Fiamma, M.; Lawrence, B. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 2001, 20, 7874-7887.
3. Scheffner, M.; Whitaker, N.J. Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin Cancer Biol 2003, 13, 59-67.
4. Talis, A.L.; Huibregtse, J.M.; Howley, P.M. The Role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem 1998, 273, 6349-6445.
5. Kuballa, P.; Matentzoglu, K.; Scheffner, M. The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. J Biol Chem 2007, 282, 65-71. (Pubitemid 47076595)
6. Kumar, A.; Zhao, Y.; Meng, G.; Zeng, M.; Srinivasan, S.; Delmolino, L.M.; Gao, Q.; Dimri, G.;Weber, G.F.;Wazer, D.E.; Band, H.; Band, V. Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol Cell Biol 2002, 22, 5801-5812.
7. Saleh, A.; Lang, V.; Cook, R.; Brandl, C.J. Identification of native complexes containing the yeast coactivator/repressor proteins NGG1/ADA3 and ADA2. J Biol Chem 1997, 272, 5571-5578.
8. Horiuchi, J.; Silverman, N.; Marcus, G.A.; Guarente, L. ADA3, a putative transcriptional adaptor, consists of two separable domains and interacts with ADA2 and GCN5 in trimeric complex. Mol Cell Biol 1995, 15, 1203-1209.
9. Sterner, D.E.; Berger, S.L. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 2000, 64, 435-459.
10. Wang, T.; Kobayashi, T.; Takimoto, R.; Denes, A.E.; Snyder, E.L.; el-Deiry,W.S.; Brachmann, R.K. hADA3 is required for p53 activity. EMBO J 2001, 20, 6404-6413.
11. Nag, A.; Germaniuk-Kurowska, A.; Dimri, M.; Sassack, M.A.; Gurumurthy, C.B.; Gao, Q.; Dimri, G.; Band, H.; Band, V. An essential role of human Ada3 in p53 acetylation. J Biol Chem 2007, 282, 8812-8820. (Pubitemid 47093537)
12. Henriksson, A.; Almlof, T.; Ford, J.; McEwan, I.J.; Gustafsson, J.A.; Wright, A.P. Role of the Ada adaptor complex in gene activation by the glucocorticoid receptor. Mol Cell Biol 1997, 17, 3065-3073. (Pubitemid 27215021)
13. vom Baur, E.; Harbers, M.; Um, S.J.; Benecke, A.; Chambon, P.; Losson, R. The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors. Genes Dev 1998, 12, 1278-1289.
14. Anafi, M.; Yang, Y.F.; Barlev, N.A.; Govindan, M.V.; Berger, S.L.; Butt, T.R.; Walfish, P.G. GCN5 and ADA adaptor proteins regulate triiodo-thyronine/ GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor. Mol Endocrinol 2000, 14, 718-732.
15. Meng, G.; Zhao, Y.; Nag, A.; Zeng, M.; Dimri, G.; Gao, Q.; Wazer, D.E.; Kumar, R.; Band, H.; Band, V. Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation. J Biol Chem 2004, 279, 54230-54240. (Pubitemid 40053160)
16. Huibregtse, J.M.; Scheffner, M.; Howley, P.M. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 1993, 13, 775-784. (Pubitemid 23040242)
17. Scheffner, M.; Huibregtse, J.M.; Vierstra, R.D.; Howley, P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75, 495-505. (Pubitemid 23335075)
18. Gao, Q.; Srinivasan, S.; Boyer, S.N.;Wazer, D.E.; Band, V. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol Cell Biol 1999, 19, 733-744.
19. Nakagawa, S.; Huibregtse, J.M. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and E6AP ubiquitin-protein ligase. Mol Cell Biol 2000, 20, 8244-8253.
20. Kuhne, C.; Banks, L. E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J Biol Chem 1998, 273, 34302-34309. (Pubitemid 29008907)
21. Glaunsinger, B.A.; Lee, S.S.; Thomas, M.; Banks, L.; Javier, R. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 2000, 19, 5270-5280
22. Lee, S.S.; Glaunsinger, B.; Mantovani, F.; Banks, L.; Javier, R.T. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol 2000, 74, 9680-9693.